{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:41:33Z","timestamp":1762105293760,"version":"build-2065373602"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00063-024-01154-8","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T13:05:20Z","timestamp":1719320720000},"page":"426-433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u00dcberdosierung von direkten oralen Antikoagulanzien","Overdosing of direct oral anticoagulants"],"prefix":"10.1007","volume":"120","author":[{"given":"Marie Anne-Catherine","family":"Neumann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00eblle","family":"Sieg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Garcia Borrega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"H\u00fcser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Caspers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Shimabukuro-Vornhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"B\u00f6ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Kochanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis A.","family":"Eichenauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6420-7938","authenticated-orcid":false,"given":"Jan-Hendrik","family":"Naendrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"key":"1154_CR1","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jacc.2020.07.045","volume":"76","author":"AJ Camm","year":"2020","unstructured":"Camm\u00a0AJ, Cools\u00a0F, Virdone\u00a0S et\u00a0al (2020) Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants. J\u00a0Am Coll Cardiol 76:1425\u20131436. https:\/\/doi.org\/10.1016\/j.jacc.2020.07.045","journal-title":"J Am Coll Cardiol"},{"key":"1154_CR2","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1111\/jth.13117","volume":"13","author":"C Chai-Adisaksopha","year":"2015","unstructured":"Chai-Adisaksopha\u00a0C, Hillis\u00a0C, Lim\u00a0W et\u00a0al (2015) Hemodialysis for the treatment of dabigatran-associated bleeding: a\u00a0case report and systematic review. J\u00a0Thromb Haemost 13:1790\u20131798. https:\/\/doi.org\/10.1111\/jth.13117","journal-title":"J Thromb Haemost"},{"key":"1154_CR3","doi-asserted-by":"publisher","first-page":"e13746","DOI":"10.1111\/eci.13746","volume":"52","author":"M Delrue","year":"2022","unstructured":"Delrue\u00a0M, Chevillard\u00a0L, St\u00e9panian\u00a0A et\u00a0al (2022) Case series of massive direct oral anticoagulant ingestion\u2014Treatment and pharmacokinetics data. Eur J Clin Invest 52:e13746. https:\/\/doi.org\/10.1111\/eci.13746","journal-title":"Eur J Clin Invest"},{"key":"1154_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9050445","author":"C Dunois","year":"2021","unstructured":"Dunois\u00a0C (2021) Laboratory Monitoring of Direct Oral Anticoagulants (DOACs). Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9050445","journal-title":"Biomedicines"},{"key":"1154_CR5","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1111\/JTH.15048","volume":"18","author":"L Franco","year":"2020","unstructured":"Franco\u00a0L, Becattini\u00a0C, Beyer-Westendorf\u00a0J et\u00a0al (2020) Definition of major bleeding: Prognostic classification. J\u00a0Thromb Haemost 18:2852\u20132860. https:\/\/doi.org\/10.1111\/JTH.15048","journal-title":"J Thromb Haemost"},{"key":"1154_CR6","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1056\/NEJMc1112874","volume":"366","author":"P Harper","year":"2012","unstructured":"Harper\u00a0P, Young\u00a0L, Merriman\u00a0E (2012) Bleeding Risk with Dabigatran in the Frail Elderly. N\u00a0Engl J Med 366:864\u2013866. https:\/\/doi.org\/10.1056\/NEJMc1112874","journal-title":"N Engl J Med"},{"key":"1154_CR7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/ejcts\/ezw313","volume":"50","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof\u00a0P, Benussi\u00a0S, Kotecha\u00a0D et\u00a0al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 50:e1\u2013e88. https:\/\/doi.org\/10.1093\/ejcts\/ezw313","journal-title":"Eur J Cardiothorac Surg"},{"key":"1154_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3238\/arztebl.2016.0575","volume":"113","author":"M Maegele","year":"2016","unstructured":"Maegele\u00a0M, Grottke\u00a0O, Sch\u00f6chl\u00a0H et\u00a0al (2016) Direct Oral Anticoagulants in Emergency Trauma Admissions. Dtsch \u00c4rztebl Int 113:575\u2013582. https:\/\/doi.org\/10.3238\/arztebl.2016.0575","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"1154_CR9","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/jth.13323","volume":"14","author":"K Martin","year":"2016","unstructured":"Martin\u00a0K, Beyer-Westendorf\u00a0J, Davidson\u00a0BL et\u00a0al (2016) Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH. J\u00a0Thromb Haemost 14:1308\u20131313. https:\/\/doi.org\/10.1111\/jth.13323","journal-title":"J Thromb Haemost"},{"key":"1154_CR10","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1161\/CIRCULATIONAHA.121.057844","volume":"147","author":"TJ Milling","year":"2023","unstructured":"Milling\u00a0TJ, Middeldorp\u00a0S, Xu\u00a0L et\u00a0al (2023) Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors. Circulation 147:1026\u20131038. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.057844","journal-title":"Circulation"},{"key":"1154_CR11","first-page":"1042","volume":"114","author":"F Osterloh","year":"2017","unstructured":"Osterloh\u00a0F (2017) Arzneimittel: Die zehn umsatzst\u00e4rksten Medikamente. Dtsch Arztbl 114:1042","journal-title":"Dtsch Arztbl"},{"key":"1154_CR12","unstructured":"Paul-Ehrlich-Institut (2020) Rote-Hand-Brief zu Ondexxya\u00ae (Andexanet alfa): Kommerzielle Anti-FXa-Aktivit\u00e4tstests sind nach der Verabreichung von Andexanet alfa f\u00fcr die Messung der Anti-FXa-Aktivit\u00e4t ungeeignet. Langen"},{"key":"1154_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1056\/NEJMoa1707278","volume":"377","author":"CV Pollack","year":"2017","unstructured":"Pollack\u00a0CV, Reilly\u00a0PA, van Ryn\u00a0J et\u00a0al (2017) Idarucizumab for Dabigatran Reversal\u2014Full Cohort Analysis. N\u00a0Engl J Med 377:431\u2013441. https:\/\/doi.org\/10.1056\/NEJMoa1707278","journal-title":"N Engl J Med"},{"key":"1154_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.122.062779","volume":"147","author":"H Reinecke","year":"2023","unstructured":"Reinecke\u00a0H, Engelbertz\u00a0C, Bauersachs\u00a0R et\u00a0al (2023) A Randomized Controlled Trial Comparing Apixaban With the Vitamin\u00a0K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study. Circulation 147:296\u2013309. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062779","journal-title":"Circulation"},{"key":"1154_CR15","doi-asserted-by":"publisher","first-page":"991675","DOI":"10.3389\/fcvm.2022.991675","volume":"9","author":"SD Sahli","year":"2022","unstructured":"Sahli\u00a0SD, Castellucci\u00a0C, Roche\u00a0TR et\u00a0al (2022) The impact of direct oral anticoagulants on viscoelastic testing\u2014A systematic review. Front Cardiovasc Med 9:991675. https:\/\/doi.org\/10.3389\/fcvm.2022.991675","journal-title":"Front Cardiovasc Med"},{"key":"1154_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/J.BLRE.2016.08.006","volume":"31","author":"BT Samuelson","year":"2017","unstructured":"Samuelson\u00a0BT, Cuker\u00a0A (2017) Measurement and reversal of the direct oral anticoagulants. Blood Rev 31:77\u201384. https:\/\/doi.org\/10.1016\/J.BLRE.2016.08.006","journal-title":"Blood Rev"},{"key":"1154_CR17","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","volume":"39","author":"J Steffel","year":"2018","unstructured":"Steffel\u00a0J, Verhamme\u00a0P, Potpara\u00a0TS et\u00a0al (2018) The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin\u00a0K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart\u00a0J 39:1330\u20131393. https:\/\/doi.org\/10.1093\/eurheartj\/ehy136","journal-title":"Eur Heart J"},{"key":"1154_CR18","series-title":"Cardiol","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1016\/j.jacc.2017.09.1085","volume-title":"2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A\u00a0Report of the American College of Cardiology Task Force on","author":"GF Tomaselli","year":"2017","unstructured":"Tomaselli\u00a0GF, Mahaffey\u00a0KW, Cuker\u00a0A et\u00a0al (2017) 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A\u00a0Report of the American College of Cardiology Task Force on. Cardiol, Bd. 70. Expert, Consensus Decision Pathways. J\u00a0Am Coll, S\u00a03042\u20133067 https:\/\/doi.org\/10.1016\/j.jacc.2017.09.1085"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01154-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-024-01154-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01154-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T09:44:29Z","timestamp":1748252669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-024-01154-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1154"],"URL":"https:\/\/doi.org\/10.1007\/s00063-024-01154-8","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"type":"print","value":"2193-6218"},{"type":"electronic","value":"2193-6226"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"assertion":[{"value":"1 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Analog der ICMJE disclosure form hat M.\u00a0Kochanek \u201eStock\u201c oder \u201eStock options\u201c von BioNTech, die nicht im Zusammenhang mit dem vorliegenden Manuskript stehen. Bez\u00fcglich \u201eLeadership or fiduciary roles\u201c bekleidet er diese in verschiedenen Fachgesellschaften (DGIIN, DGHO, DGIM). M.A.-C. Neumann wird durch das \u201eCologne Clinician Scientist Program\u201c der Universit\u00e4t zu K\u00f6ln, K\u00f6ln, Deutschland unterst\u00fctzt. N. Sieg wird durch das Else Kr\u00f6ner Forschungskolleg Clonal Evolution in Cancer der Universit\u00e4t zu K\u00f6ln, K\u00f6ln, Deutschland unterst\u00fctzt. J.-H. Naendrup erh\u00e4lt eine Projektf\u00f6rderung durch die Else Kr\u00f6ner-Fresenius Stiftung, Deutschland, welche nicht im Bezug zu dieser Publikation steht. J. Garcia Borrega, C. H\u00fcser, M. Caspers, A. Shimabukuro-Vornhagen, B. B\u00f6ll und D.A. Eichenauer geben an, dass kein Interessenkonflikt besteht.\n Das Manuskript liegt keinem anderen Journal zur Begutachtung vor und die Daten wurden in keinem anderen Journal publiziert. Alle Autor*innen stimmen der Einreichung bei Medizinische Klinik\u00a0\u2013 Intensivmedizin und Notfallmedizin zu.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}